BDH Industries

What BDH Industries does

BDH Industries Ltd is an Indian pharmaceutical manufacturer founded in 1935 and headquartered in Mumbai, India, focused on the manufacture of therapeutic formulations. The company is publicly listed on the Bombay Stock Exchange under ticker 524828 and operates with 251-500 employees; its product portfolio centers on therapeutic pharmaceutical formulations, though specific product lines, therapeutic areas, and dosages were not disclosed in the source material. No technology stack, proprietary AI/ML capabilities, software platforms, APIs, partnerships, customer logos, distribution channels, certifications, or regulatory approvals were disclosed, and revenue is not directly reported. The firm's strategic posture reflected in available data is conservative: a routine BSE-listed mid/small-cap manufacturer continuing standard quarterly reporting cycles, holding its 36th Annual General Meeting in August 2026, and declaring a ₹5 per share dividend for FY26 - subject to shareholder approval. The principal analytical caveat is that the financials table supplied contains values inconsistent with a 251-500 employee Indian pharma manufacturer (suggesting a data/unit error in the source), and the company's web presence (bdhind.com) could not be fully fetched during data aggregation, limiting descriptive depth on products, customer mix, manufacturing footprint, and commercial channels.

Name

BDH Industries

Legal name

BDH Industries Ltd

Website

https://bdhind.com

Company type

Public

Founded year

1935

Operating status

Operating

Headcount range

251–500 employees

Short description

BDH Industries Ltd is a publicly listed Indian pharmaceutical company founded in 1935 and headquartered in Mumbai that manufactures therapeutic formulations, operating with 251-500 employees under BSE ticker 524828.

Ownership category

akta.pro rank

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales

Core offering

BDH Industries Ltd is a publicly listed Indian pharmaceutical company engaged in the manufacture of therapeutic formulations for the pharmaceutical industry. The company produces finished dosage formulations that are marketed and distributed to healthcare customers. It is incorporated in India, headquartered in Mumbai, and listed on the Bombay Stock Exchange.

Differentiator

Problem solved

Functional benefit

Products and services

• Therapeutic pharmaceutical formulations

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights1 record

Broad incumbents

• Sun Pharmaceutical Industries: Largest pharmaceutical company in India with extensive formulations manufacturing across all major therapeutic categories and global presence — operates in the same industry as BDH but at significantly greater scale and with broader geographic reach.
• Dr. Reddy's Laboratories: Larger Indian pharmaceutical company with significant formulations and API manufacturing, broader product portfolio, and global footprint — comparable to BDH in core business but operating at meaningfully greater scale.
• Cadila Healthcare (Zydus): Major Indian pharmaceutical company with formulations and biologics manufacturing, broader product portfolio and greater scale than BDH but facing similar domestic market dynamics, regulatory requirements, and pricing pressures.

Direct peers

• Torrent Pharmaceuticals: Indian pharmaceutical manufacturer with a formulations focus across therapeutic areas, with a similar operational profile to BDH in terms of product categories, customer segments, and regulatory requirements.
• Lupin: Indian pharmaceutical company engaged in finished-formulations manufacturing across cardiovascular, diabetes, and other therapeutic segments, comparable to BDH in product categories, regulatory exposure, and domestic market dynamics.
• Ipca Laboratories: Mid-sized Indian pharmaceutical manufacturer producing formulations and APIs with overlapping therapeutic categories and emerging-market distribution — closer to BDH in scale than the largest Indian pharma incumbents.
• Ajanta Pharma: Indian pharmaceutical manufacturer focused on branded generic formulations across specialties, with comparable size and similar product positioning in domestic and emerging markets to BDH.
• Cipla: Major Indian pharmaceutical manufacturer with broad finished-formulations portfolio across multiple therapeutic areas, directly comparable to BDH as a domestic formulations manufacturer serving similar customer segments in India and emerging markets.
• Glenmark Pharmaceuticals: Indian pharmaceutical company engaged in formulations and specialty medicines with comparable regulatory exposure and Indian market dynamics, although operating at larger scale than BDH.
• Alembic Pharmaceuticals: Indian pharmaceutical company with formulations manufacturing operations across multiple therapeutic areas, similar to BDH in product mix and domestic market focus, listed on Indian exchanges.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/bdhind

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BDH Industries